-
1 Comment
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 1.6% below its 200 day moving average.
From a valuation standpoint, the stock is 35.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 13.0.
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's total revenue rose by 17.1% to $763M since the same quarter in the previous year.
Its net income has increased by 28.4% to $205M since the same quarter in the previous year.
Finally, its free cash flow grew by 13.5% to $-305M since the same quarter in the previous year.
Based on the above factors, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd gets an overall score of 3/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100002WP3 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| PE Ratio | 26.37 |
|---|---|
| Target Price | 20.85 |
| Dividend Yield | 0.8% |
| Beta | 0.65 |
| Market Cap | 18B |
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. It also provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium, cisatracurium, calcium folinate, doxorubicin, milrinone, bleomycin, carboplatin, cytarabine, topotecan hydrochloride, phenylephrine hydrochloride, ganirelix acetate, furosemide, glycopyrrolate, neostigmine methylsulfate, succinylcholine chloride, reganosin, isoflurane blue, clofarabine, haloperidol decanoate, busulfan, gemcitabine hydrochloride, dexmedetomidine hydrochloride, nelarabine, rocuronium bromide, zoledronic acid, bupivacaine hydrochloride, plerixafor, eptifibatide, fondaparinux sodium, docetaxel, fluorouracil, palonosetron hydrochloride, oxaliplatin, fulvestrant, and adalimumab injections. The company offers bortezomib, bendamustine hydrochloride, mycophenolate mofetil, vancomycin hydrochloride, daptomycin, decitabine, voriconazole, tigecycline, melphalan hydrochloride, actinomycin, micafungin, azacitidine, pantoprazole sodium, mitomycin, pemetrexed disodium, thiotepa, and dacarbazine for injections. Its injection products cover anticoagulation, anti-tumor, cardiovascular disease, as well as surgical anesthesia, anti-bacterial infection, and angiography. Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. was founded in 2000 and is headquartered in Nanjing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603707.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
